Medication info

Rimetpol Tablet 1/250mg

Prescription medicationTabletOralExpired
Ingredient · strength
Glimepiride›1mg / 1 tabletMetformin Hydrochloride›250mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle - 30 tablets/bottle, 100 tablets/bottle - 100 tablets/bottle
Approval status
Expired

MFDS item code 201906508 · Approved 2019.09.18

This product's status changed to Expired on 2024.09.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered once or twice daily immediately before or with meals. The dose may be adjusted according to each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose based on blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. For glimepiride as a single agent, there is generally little additional effect at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for concomitant therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken together. Even if a previous dose was missed, do not take more than a single dose at the next administration.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medicine is used in patients with non-insulin-dependent diabetes mellitus, namely type 2 diabetes. It is especially effective when blood sugar control is insufficient with monotherapy using glimepiride or metformin, while also following dietary and exercise regimens. It can also be used instead of combination therapy with glimepiride and metformin. This helps to better manage blood sugar levels. It is used to improve blood sugar control in diabetic patients.

How to take

Adult dose

This medicine is administered once or twice daily immediately before or with meals. The dose may be adjusted according to each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose based on blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. For glimepiride as a single agent, there is generally little additional effect at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for concomitant therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken together. Even if a previous dose was missed, do not take more than a single dose at the next administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is needed. In particular, if renal function declines rapidly, the drug may accumulate in the body, increasing the risk of lactic acidosis, so kidney function should be checked regularly. If there are signs of dehydration or severe diarrhea, vomiting, fever, etc., it is advisable to temporarily stop administration and consult a doctor. Moreover, when combined with other drugs that may affect kidney function, careful observation is required to prevent deterioration of kidney function. This medicine should not be administered to patients with insulin-dependent diabetes mellitus or acute metabolic acidosis, or severe liver or kidney functional impairment. It is also recommended that pregnant or breastfeeding women do not use this medicine. Patients with a high risk of hypoglycemia, particularly the elderly or those with irregular meals or poor nutritional status, require careful monitoring and dosage adjustment. Gastrointestinal symptoms (such as diarrhea, nausea, vomiting) can commonly occur during initial treatment but are usually temporary and may be alleviated by taking it with meals. If serious allergic reactions occur, inform medical personnel immediately, and hematological adverse reactions should also be monitored closely. This medicine may interact with other medications, so it is important to inform medical staff of all medications being taken and regular blood glucose and kidney function tests are necessary. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid alcohol. This medicine has not been sufficiently verified for safety and efficacy in children, so caution should be exercised in its use. Elderly patients often have reduced kidney function, so it is recommended to adjust the dosage and conduct regular kidney function tests. In case of overdose, hypoglycemia or lactic acidosis may occur, so immediate medical attention is necessary. Additionally, caution is required when driving or operating machinery due to the risk of accidents from hypoglycemia or other side effects. Store this medicine out of the reach of children and do not transfer it to another container.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal bloating
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
Show 40 more
  • metallic taste
  • visual impairment
  • erythema
  • pruritus
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • granulocytopenia
  • agranulocytosis
  • pancytopenia
  • megaloblastic anemia
  • increased liver enzymes
  • liver dysfunction
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • abdominal pain
  • abdominal bloating
  • vomiting
  • dyspepsia
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma
  • vertigo
  • liver dysfunction
  • arthralgia
  • facial edema
  • erectile dysfunction
  • hair loss
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Furthermore, it is important to store it at room temperature between 1°C and 30°C to maintain the drug's effectiveness.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle - 30 tablets/bottle, 100 tablets/bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.